المؤلفون: Peng Xu, Wen Luo, Jingjing Hu, Xiaobin Ma, Qian Hao, Wentao Hui, Zhangjian Zhou, Shuai Lin, Meng Wang, Hao Wu, Zhijun Dai, Huafeng Kang

المصدر: Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)

مصطلحات موضوعية: HR‐positive/HER2‐negative breast cancer, National Cancer Database, neoadjuvant endocrine treatment, overall survival, surgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/eb9593224bde4f95ab8315a76226dc2b

المؤلفون: Xinyu Ren, Yu Song, Yanna zhang, Huanwen Wu, Longyun Chen, Junyi Pang, Liangrui Zhou, Songjie Shen, Zhiyong Liang

المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)

مصطلحات موضوعية: HR-positive/HER2-negative breast cancer, Immune rescore, Intrinsic subtype, Risk of recurrence, Tumor-infiltrating lymphocyte, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/c0a6a3610d224ccb85a3dbebb34e8667

المؤلفون: Ren, Xinyu, Song, Yu, zhang, Yanna, Wu, Huanwen, Chen, Longyun, Pang, Junyi, Zhou, Liangrui, Shen, Songjie^{Aff2, IDs12885022096564_cor8}, Liang, Zhiyong^{Aff1, IDs12885022096564_cor9}

المصدر: BMC Cancer. 22(1)

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, Sara Parola, Anna Ventriglia, Antonio Doronzo, Mattia Garutti, Armando Orlandi, Antonella Palazzo, Alessandra Fabi, Emilio Bria, Giampaolo Tortora, Grazia Arpino, Mario Giuliano, Lucia Del Mastro, Michelino De Laurentiis, Fabio Puglisi

مصطلحات موضوعية: Survival, Receptor, ErbB-2, Gene expression assays, HR-positive/HER2-negative breast cancer, Neoadjuvant chemotherapy, Neoadjuvant endocrine therapy, Pathological response, Gene Expression, Breast Neoplasms, General Medicine, Hormones, Neoadjuvant Therapy, Oncology, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Radiology, Nuclear Medicine and imaging, Prospective Studies, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df56aebe0523925d7f957c9f6aac165
http://hdl.handle.net/11390/1232249

المؤلفون: Ahmad, Awada, Joseph, Gligorov, Guy, Jerusalem, Matthias, Preusser, Christian, Singer, Christoph, Zielinski

المصدر: ESMO Open

مصطلحات موضوعية: Antineoplastic Agents, Hormonal, Breast Neoplasms, Review, chemotherapy, aromatase inhibitors, endocrine resistance, CDK4/6 inhibitors, breast cancer, Clinical Protocols, Antineoplastic Combined Chemotherapy Protocols, HR-positive/HER2-negative breast cancer, Humans, Breast, Protein Kinase Inhibitors, Mastectomy, Clinical Trials as Topic, endocrine therapy, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Progression-Free Survival, Tumor Burden, Chemotherapy, Adjuvant, Practice Guidelines as Topic, Female, metastatic breast cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::ac65e2708a01988b44036bb249cdc38a
https://pubmed.ncbi.nlm.nih.gov/31798979

المؤلفون: Christian F. Singer, Joseph Gligorov, Ahmad Awada, Matthias Preusser, Christoph Zielinski, Guy Jerusalem

المساهمون: Jules Bordet Institute [Bruxelles], Université Libre de Bruxelles [Bruxelles] (ULB), Sorbonne Université (SU), CHU Tenon [APHP], Centre Hospitalier Universitaire de Liège (CHU-Liège), Université de Liège, Medical University of Vienna, Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Université libre de Bruxelles (ULB), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Medizinische Universität Wien = Medical University of Vienna

المصدر: European Society for Medical Oncology
European Society for Medical Oncology, BMJ Journals, 2019, 4 (6), pp.e000565. ⟨10.1136/esmoopen-2019-000565⟩
ESMO Open, Vol 4, Iss 6 (2019)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease, chemotherapy, lcsh:RC254-282, aromatase inhibitors, endocrine resistance, 03 medical and health sciences, CDK4/6 inhibitors, 0302 clinical medicine, Breast cancer, breast cancer, Internal medicine, HR-positive/HER2-negative breast cancer, medicine, Lymph node, Chemotherapy, Aromatase inhibitor, business.industry, endocrine therapy, Cancer, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastatic breast cancer, 3. Good health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, metastatic breast cancer, CDK4/6 Inhibition, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446002c379a13fa979bf1805e0740f0e
https://hal.sorbonne-universite.fr/hal-02512197

المؤلفون: Awada, Ahmad, Gligorov, Joseph, Jerusalem, Guy, Preusser, Matthias, Singer, Christian, Zielinski, Christoph

المصدر: ESMO Open, 4 (6), e000565 (2019)

مصطلحات موضوعية: CDK4/6 inhibitors, HR-positive/HER2-negative breast cancer, aromatase inhibitors, breast cancer, chemotherapy, endocrine resistance, endocrine therapy, metastatic breast cancer, oncology, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

Relation: urn:issn:2059-7029

URL الوصول: https://orbi.uliege.be/handle/2268/245257

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.